<?xml version="1.0" encoding="UTF-8"?>
<p>The chemotherapy infusion unit should function at usual capacity to avoid cancer treatment delays. Patients on active outpatient anticancer therapy can be categorized into oral or intravenous therapy, and consideration for switching intravenous chemotherapy to acceptable alternative oral anticancer drugs may be considered on a case‐by‐case basis. For example, fluorouracil can be substituted for capecitabine in concurrent neoadjuvant chemoradiation for rectal cancer without compromising oncological outcome 
 <xref rid="onco13306-bib-0038" ref-type="ref">38</xref>, 
 <xref rid="onco13306-bib-0039" ref-type="ref">39</xref>. This strategy can reduce the patient's visit time and, hence, risk of exposure to SARS‐CoV‐2. Another potential suggestion is to consider home infusion of chemotherapy if medically and logistically feasible 
 <xref rid="onco13306-bib-0040" ref-type="ref">40</xref>.
</p>
